Analysing the eosinophil cationic protein - a clue to the function of the eosinophil granulocyte
Open Access
- 1 December 2011
- journal article
- review article
- Published by Springer Nature in Respiratory Research
- Vol. 12 (1) , 10
Abstract
Eosinophil granulocytes reside in respiratory mucosa including lungs, in the gastro-intestinal tract, and in lymphocyte associated organs, the thymus, lymph nodes and the spleen. In parasitic infections, atopic diseases such as atopic dermatitis and asthma, the numbers of the circulating eosinophils are frequently elevated. In conditions such as Hypereosinophilic Syndrome (HES) circulating eosinophil levels are even further raised. Although, eosinophils were identified more than hundred years ago, their roles in homeostasis and in disease still remain unclear. The most prominent feature of the eosinophils are their large secondary granules, each containing four basic proteins, the best known being the eosinophil cationic protein (ECP). This protein has been developed as a marker for eosinophilic disease and quantified in biological fluids including serum, bronchoalveolar lavage and nasal secretions. Elevated ECP levels are found in T helper lymphocyte type 2 (atopic) diseases such as allergic asthma and allergic rhinitis but also occasionally in other diseases such as bacterial sinusitis. ECP is a ribonuclease which has been attributed with cytotoxic, neurotoxic, fibrosis promoting and immune-regulatory functions. ECP regulates mucosal and immune cells and may directly act against helminth, bacterial and viral infections. The levels of ECP measured in disease in combination with the catalogue of known functions of the protein and its polymorphisms presented here will build a foundation for further speculations of the role of ECP, and ultimately the role of the eosinophil.Keywords
This publication has 163 references indexed in Scilit:
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Functional extracellular eosinophil granules: novel implications in eosinophil immunobiologyCurrent Opinion in Immunology, 2009
- Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6Blood, 2009
- Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming ActivityThe Journal of Immunology, 2009
- Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitorJournal of Experimental Medicine, 2008
- Post-translational Tyrosine Nitration of Eosinophil Granule Toxins Mediated by Eosinophil PeroxidaseJournal of Biological Chemistry, 2008
- Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2–MyD88 signal pathway in dendritic cells and enhances Th2 immune responsesJournal of Experimental Medicine, 2008
- Resolution of in flammation: state of the art, definitions and termsThe FASEB Journal, 2007
- Eosinophil Activity inSchistosoma mansoniInfections In Vivo and In Vitro in Relation to Plasma Cytokine Profile Pre- and Posttreatment with PraziquantelClinical and Vaccine Immunology, 2006
- The eosinophil and cutaneous edemaJournal of the American Academy of Dermatology, 1986